STAA Fundamental Analysis - STAAR SURGICAL CO

Fundamental Rating

Overall STAA gets a fundamental rating of 4 out of 10. We evaluated STAA against 188 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for STAA as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, STAA is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

STAA had negative earnings in the past year.

STAA had a negative operating cash flow in the past year.

Of the past 5 years STAA 4 years were profitable.

STAA had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of STAA (-15.54%) is comparable to the rest of the industry.

With a decent Return On Equity value of -20.31%, STAA is doing good in the industry, outperforming 61.70% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-15.54%
ROE	-20.31%
ROIC	N/A

ROA(3y)3.25%

ROA(5y)3.83%

ROE(3y)4.04%

ROE(5y)4.92%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Gross Margin of STAA (74.00%) is better than 86.17% of its industry peers.

In the last couple of years the Gross Margin of STAA has remained more or less at the same level.

STAA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	74%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.5%

GM growth 5Y0.47%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

STAA does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for STAA has been increased compared to 1 year ago.

The number of shares outstanding for STAA has been increased compared to 5 years ago.

Compared to 1 year ago, STAA has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 5.52 indicates that STAA is not in any danger for bankruptcy at the moment.

The Altman-Z score of STAA (5.52) is better than 78.19% of its industry peers.

There is no outstanding debt for STAA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	5.52

ROIC/WACCN/A

WACC9.06%

2.3 Liquidity

STAA has a Current Ratio of 4.78. This indicates that STAA is financially healthy and has no problem in meeting its short term obligations.

STAA's Current ratio of 4.78 is fine compared to the rest of the industry. STAA outperforms 71.81% of its industry peers.

A Quick Ratio of 4.07 indicates that STAA has no problem at all paying its short term obligations.

With a decent Quick ratio value of 4.07, STAA is doing good in the industry, outperforming 73.94% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	4.78
Quick Ratio	4.07

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

STAA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -145.31%.

Measured over the past 5 years, STAA shows a small growth in Earnings Per Share. The EPS has been growing by 7.49% on average per year.

STAA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.44%.

Measured over the past years, STAA shows a quite strong growth in Revenue. The Revenue has been growing by 15.88% on average per year.

EPS 1Y (TTM)-145.31%

EPS 3Y-12.35%

EPS 5Y7.49%

EPS Q2Q%-688.89%

Revenue 1Y (TTM)-14.44%

Revenue growth 3Y10.84%

Revenue growth 5Y15.88%

Sales Q2Q%-44.94%

3.2 Future

STAA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.94% yearly.

Based on estimates for the next years, STAA will show a small growth in Revenue. The Revenue will grow by 2.99% on average per year.

EPS Next Y-606.14%

EPS Next 2Y-68.92%

EPS Next 3Y-33.46%

EPS Next 5Y16.94%

Revenue Next Year-24.23%

Revenue Next 2Y-1.41%

Revenue Next 3Y1.38%

Revenue Next 5Y2.99%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for STAA. In the last year negative earnings were reported.

With a Price/Forward Earnings ratio of 558.75, STAA can be considered very expensive at the moment.

62.77% of the companies in the same industry are more expensive than STAA, based on the Price/Forward Earnings ratio.

STAA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.15.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	558.75

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as STAA's earnings are expected to decrease with -33.46% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-68.92%

EPS Next 3Y-33.46%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for STAA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

STAAR SURGICAL CO

NASDAQ:STAA (5/30/2025, 8:00:00 PM)

After market: 17.81 0 (0%)

17.81

-0.52 (-2.84%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)05-07 2025-05-07/amc

Earnings (Next)08-05 2025-08-05/amc

Inst Owners100.92%

Inst Owner Change8.76%

Ins Owners0.42%

Ins Owner Change18.93%

Market Cap882.13M

Analysts71

Price Target22.04 (23.75%)

Short Float %12.61%

Short Ratio6.19

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-1693.07%

Min EPS beat(2)-3398.76%

Max EPS beat(2)12.63%

EPS beat(4)3

Avg EPS beat(4)-804.54%

Min EPS beat(4)-3398.76%

Max EPS beat(4)120.44%

EPS beat(8)5

Avg EPS beat(8)-392.44%

EPS beat(12)9

Avg EPS beat(12)-233.83%

EPS beat(16)12

Avg EPS beat(16)-144.65%

Revenue beat(2)1

Avg Revenue beat(2)-17.15%

Min Revenue beat(2)-37.91%

Max Revenue beat(2)3.61%

Revenue beat(4)2

Avg Revenue beat(4)-8.1%

Min Revenue beat(4)-37.91%

Max Revenue beat(4)3.61%

Revenue beat(8)3

Avg Revenue beat(8)-4.68%

Revenue beat(12)4

Avg Revenue beat(12)-2.78%

Revenue beat(16)6

Avg Revenue beat(16)-1.16%

PT rev (1m)-2.09%

PT rev (3m)-2.09%

EPS NQ rev (1m)-17.06%

EPS NQ rev (3m)-17.06%

EPS NY rev (1m)-85.36%

EPS NY rev (3m)-85.36%

Revenue NQ rev (1m)-1.02%

Revenue NQ rev (3m)-1.02%

Revenue NY rev (1m)-0.46%

Revenue NY rev (3m)-0.56%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	558.75
P/S	3.16
P/FCF	N/A
P/OCF	N/A
P/B	2.52
P/tB	2.53
EV/EBITDA	N/A

EPS(TTM)-0.29

EYN/A

EPS(NY)0.03

Fwd EY0.18%

FCF(TTM)-0.63

FCFYN/A

OCF(TTM)-0.24

OCFYN/A

SpS5.64

BVpS7.07

TBVpS7.03

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-15.54%
ROE	-20.31%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	74%
FCFM	N/A

ROA(3y)3.25%

ROA(5y)3.83%

ROE(3y)4.04%

ROE(5y)4.92%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.5%

GM growth 5Y0.47%

F-Score2

Asset Turnover0.61

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	246.03%
Cap/Sales	7.04%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	4.78
Quick Ratio	4.07
Altman-Z	5.52

F-Score2

WACC9.06%

ROIC/WACCN/A

Cap/Depr(3y)365.33%

Cap/Depr(5y)348.39%

Cap/Sales(3y)6.49%

Cap/Sales(5y)6.1%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-145.31%

EPS 3Y-12.35%

EPS 5Y7.49%

EPS Q2Q%-688.89%

EPS Next Y-606.14%

EPS Next 2Y-68.92%

EPS Next 3Y-33.46%

EPS Next 5Y16.94%

Revenue 1Y (TTM)-14.44%

Revenue growth 3Y10.84%

Revenue growth 5Y15.88%

Sales Q2Q%-44.94%

Revenue Next Year-24.23%

Revenue Next 2Y-1.41%

Revenue Next 3Y1.38%

Revenue Next 5Y2.99%

EBIT growth 1Y-295.74%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-543.45%

EBIT Next 3Y80.58%

EBIT Next 5Y61.9%

FCF growth 1Y-286.93%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-133.17%

OCF growth 3Y-29.01%

OCF growth 5Y-9.43%

STAAR SURGICAL CO (STAA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens